NCT00830414View on ClinicalTrials.gov

Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women

PHASE1CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

September 30, 2002

Study Completion Date

September 30, 2002

Conditions
Healthy
Interventions
DRUG

medroxyprogesterone acetate

IM Injection

DRUG

medroxyprogesterone acetate

IM injection

Trial Locations (1)

Unknown

AAI Deutschland GmbH & Co. KG, Neu-Ulm

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00830414 - Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women | Biotech Hunter | Biotech Hunter